Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 579751, 12 pages
http://dx.doi.org/10.1155/2013/579751
Research Article

Anti-Bladder-Tumor Effect of Baicalein from Scutellaria baicalensis Georgi and Its Application In Vivo

1Department of Microbiology, Immunology and Biopharmaceuticals, College of Life Sciences, National Chiayi University, No. 300 Syuefu Road, Chiayi 600, Taiwan
2Department of Internal Medicine, Buddhist Tzuchi Dalin General Hospital, Dalin Town, Chiayi 622, Taiwan
3Department of Pathology, Chiayi Christian Hospital, Chiayi 600, Taiwan

Received 16 November 2012; Revised 22 January 2013; Accepted 5 February 2013

Academic Editor: Jen-Hwey Chiu

Copyright © 2013 Jin-Yi Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Siegel, D. Naishadham, and A. Jemal, “Cancer statistics 2012,” A Cancer Journal for Clinicians, vol. 62, no. 1, pp. 10–29, 2012. View at Google Scholar
  3. D. J. McConkey, S. Lee, W. Choi et al., “Molecular genetics of bladder cancer: emerging mechanisms of tumor initiation and progression,” Urologic Oncology, vol. 28, no. 4, pp. 429–440, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. X. R. Wu, “Urothelial tumorigenesis: a tale of divergent pathways,” Nature Reviews Cancer, vol. 5, no. 9, pp. 713–725, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. L. C. Pagliaro and P. Sharma, “Review of metastatic bladder cancer,” Minerva Urologica e Nefrologica, vol. 58, no. 1, pp. 53–71, 2006. View at Google Scholar · View at Scopus
  6. C. C. Lin and D. E. Shieh, “The anti-inflammatory activity of Scutellaria rivularis extracts and its active components, baicalin, baicalein and wogonin,” American Journal of Chinese Medicine, vol. 24, no. 1, pp. 31–36, 1996. View at Google Scholar · View at Scopus
  7. Z. H. Shao, T. L. Vanden Hoek, Y. Qin et al., “Baicalein attenuates oxidant stress in cardiomyocytes,” American Journal of Physiology, vol. 282, no. 3, pp. H999–H1006, 2002. View at Google Scholar · View at Scopus
  8. L. G. Chen, L. Y. Hung, K. W. Tsai et al., “Wogonin, a bioactive flavonoid in herbal tea, inhibits inflammatory cyclooxygenase-2 gene expression in human lung epithelial cancer cells,” Molecular Nutrition and Food Research, vol. 52, no. 11, pp. 1349–1357, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. J. I. Chao, W. C. Su, and H. F. Liu, “Baicalein induces cancer cell death and proliferation retardation by the inhibition of CDC2 kinase and survivin associated with opposite role of p38 mitogen-activated protein kinase and AKT,” Molecular Cancer Therapeutics, vol. 6, no. 11, pp. 3039–3048, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. R. H. Jiang, W. C. Su, H. F. Liu, H. S. Huang, and J. I. Chao, “Opposite expression of securin and γ-H2AX regulates baicalein-induced cancer cell death,” Journal of Cellular Biochemistry, vol. 111, no. 2, pp. 274–283, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Takahashi, M. C. Chen, H. Pham et al., “Baicalein, a component of Scutellaria baicalensis, induces apoptosis by Mcl-1 down-regulation in human pancreatic cancer cells,” Biochimica et Biophysica Acta, vol. 1813, no. 8, pp. 1465–1474, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. W. Chiu, T. H. Lin, W. S. Huang et al., “Baicalein inhibits the migration and invasive properties of human hepatoma cells,” Toxicology and Applied Pharmacology, vol. 255, no. 3, pp. 316–326, 2011. View at Google Scholar
  13. L. Wang, Y. Ling, Y. Chen et al., “Flavonoid baicalein suppresses adhesion, migration and invasion of MDA-MB-231 human breast cancer cells,” Cancer Letters, vol. 297, no. 1, pp. 42–48, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Wu, J. Li, D. Huang et al., “Baicalein mediates inhibition of migration and invasiveness of skin carcinoma through Ezrin in A431 cells,” BMC Cancer, vol. 11, article 527, 2011. View at Google Scholar
  15. J. T. Fox, S. Sakamuru, R. Huang et al., “High-throughput genotoxicity assay identifies antioxidants as inducers of DNA damage response and cell death,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 14, pp. 5423–5428, 2012. View at Google Scholar
  16. J. Y. Wu, K. T. Chung, Y. W. Liu et al., “Synthesis and biological evaluation of novel C(6) modified baicalein derivatives as antioxidative agents,” Journal of Agricultural and Food Chemistry, vol. 56, no. 8, pp. 2838–2845, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. C. H. Shen, J. J. Shee, J. Y. Wu, Y. W. Lin, J. D. Wu, and Y. W. Liu, “Combretastatin A-4 inhibits cell growth and metastasis in bladder cancer cells and retards tumour growth in a murine orthotopic bladder tumour model,” British Journal of Pharmacology, vol. 160, no. 8, pp. 2008–2027, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Y. Wu, Y. R. Lee, C. C. Huang et al., “Curcumin-induced heme oxygenase-1 expression plays a negative role for its anti-cancer effect in bladder cancers,” Food and Chemical Toxicology, vol. 50, no. 10, pp. 3530–3536, 2012. View at Google Scholar
  19. P. S. Klein and D. A. Melton, “A molecular mechanism for the effect of lithium on development,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 16, pp. 8455–8459, 1996. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Zhan, C. J. Phiel, L. Spece, N. Gurvich, and P. S. Klein, “Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium: evidence for autoregulation of GSK-3,” Journal of Biological Chemistry, vol. 278, no. 35, pp. 33067–33077, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. Q. M. Zhou, S. Wang, H. Zhang et al., “The combination of baicalin and baicalein enhances apoptosis via the ERK/p38 MAPK pathway in human breast cancer cells,” Acta Pharmacologica Sinica, vol. 30, no. 12, pp. 1648–1658, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. H. Cheng, L. A. Li, P. Lin et al., “Baicalein induces G1 arrest in oral cancer cells by enhancing the degradation of cyclin D1 and activating AhR to decrease Rb phosphorylation,” Toxicology and Applied Pharmacology, vol. 263, no. 3, pp. 360–367, 2012. View at Google Scholar
  23. H. W. C. Leung, W. H. Yang, M. Y. Lai, C. J. Lin, and H. Z. Lee, “Inhibition of 12-lipoxygenase during baicalein-induced human lung nonsmall carcinoma H460 cell apoptosis,” Food and Chemical Toxicology, vol. 45, no. 3, pp. 403–411, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. B. C. Y. Wong, W. P. Wang, C. H. Cho et al., “12-Lipoxygenase inhibition induced apoptosis in human gastric cancer cells,” Carcinogenesis, vol. 22, no. 9, pp. 1349–1354, 2001. View at Google Scholar · View at Scopus
  25. M. Bonham, J. Posakony, I. Coleman, B. Montgomery, J. Simon, and P. S. Nelson, “Characterization of chemical constituents in Scutellaria baicalensis with antiandrogenic and growth-inhibitory activities toward prostate carcinoma,” Clinical Cancer Research, vol. 11, no. 10, pp. 3905–3914, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Chen, Q. Ruan, E. Bedner et al., “Effects of the flavonoid baicalin and its metabolite baicalein on androgen receptor expression, cell cycle progression and apoptosis of prostate cancer cell lines,” Cell Proliferation, vol. 34, no. 5, pp. 293–304, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. M. K. Roy, K. Nakahara, V. Na Thalang et al., “Baicalein, a flavonoid extracted from a methanolic extract of Oroxylum indicum inhibits proliferation of a cancer cell line in vitro via induction of apoptosis,” Pharmazie, vol. 62, no. 2, pp. 149–153, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. W. H. Chang, C. H. Chen, and F. J. Lu, “Different effects of baicalein, baicalin and wogonin on mitochondrial function, glutathione content and cell cycle progression in human hepatoma cell lines,” Planta Medica, vol. 68, no. 2, pp. 128–132, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. Z. Ma, K. I. Otsuyama, S. Liu et al., “Baicalein, a component of Scutellaria radix from Huang-Lian-Jie-Du-Tang (HLJDT), leads to suppression of proliferation and induction of apoptosis in human myeloma cells,” Blood, vol. 105, no. 8, pp. 3312–3318, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Himeji, T. Ohtsuki, H. Fukazawa et al., “Difference of growth-inhibitory effect of Scutellaria baicalensis-producing flavonoid wogonin among human cancer cells and normal diploid cell,” Cancer Letters, vol. 245, no. 1-2, pp. 269–274, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Kong, Y. Zhang, T. Yamori, H. Duan, and M. Jin, “Inhibitory activity of flavonoids against class I phosphatidylinositol 3-kinase isoforms,” Molecules, vol. 16, no. 6, pp. 5159–5167, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. G. P. Pidgeon, M. Kandouz, A. Meram, and K. V. Honn, “Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells,” Cancer Research, vol. 62, no. 9, pp. 2721–2727, 2002. View at Google Scholar · View at Scopus
  33. L. Stephens, K. Anderson, D. Stokoe et al., “Prohtein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B,” Science, vol. 279, no. 5351, pp. 710–714, 1998. View at Publisher · View at Google Scholar · View at Scopus
  34. D. D. Sarbassov, D. A. Guertin, S. M. Ali, and D. M. Sabatini, “Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex,” Science, vol. 307, no. 5712, pp. 1098–1101, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. R. S. Jope, C. J. Yuskaitis, and E. Beurel, “Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics,” Neurochemical Research, vol. 32, no. 4-5, pp. 577–595, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. C. J. Hsieh, K. Hall, T. Ha, C. Li, G. Krishnaswamy, and D. S. Chi, “Baicalein inhibits IL-1β- and TNF-α-induced inflammatory cytokine production from human mast cells via regulation of the NF-κB pathway,” Clinical and Molecular Allergy, vol. 5, article 5, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. B. Y. Kang, S. W. Chung, S. H. Kim, D. Cho, and T. S. Kim, “Involvement of nuclear factor-κB in the inhibition of interleukin-12 production from mouse macrophages by baicalein, a flavonoid in Scutellaria baicalensis,” Planta Medica, vol. 69, no. 8, pp. 687–691, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. M. H. Kim, S. Y. Ryu, M. A. Bae, J. S. Choi, Y. K. Min, and S. H. Kim, “Baicalein inhibits osteoclast differentiation and induces mature osteoclast apoptosis,” Food and Chemical Toxicology, vol. 46, no. 11, pp. 3375–3382, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. C. J. Chen, S. L. Raung, S. L. Liao, and S. Y. Chen, “Inhibition of inducible nitric oxide synthase expression by baicalein in endotoxin/cytokine-stimulated microglia,” Biochemical Pharmacology, vol. 67, no. 5, pp. 957–965, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Suk, H. Lee, S. S. Kang, G. J. Cho, and W. S. Choi, “Flavonoid baicalein attenuates activation-induced cell death of brain microglia,” Journal of Pharmacology and Experimental Therapeutics, vol. 305, no. 2, pp. 638–645, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. J. I. Inoue, J. Gohda, T. Akiyama, and K. Semba, “NF-κB activation in development and progression of cancer,” Cancer Science, vol. 98, no. 3, pp. 268–274, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. G. Sethi, B. Sung, and B. B. Aggarwal, “Nuclear factor-κB activation: from bench to bedside,” Experimental Biology and Medicine, vol. 233, no. 1, pp. 21–31, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Deng, W. Xia, S. A. Miller, Y. Wen, H. Y. Wang, and M. C. Hung, “Crossregulation of NF-κB by the APC/GSK-3β/β-catenin pathway,” Molecular Carcinogenesis, vol. 39, no. 3, pp. 139–146, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. H. Z. Lee, H. W. C. Leung, M. Y. Lai, and C. H. Wu, “Baicalein induced cell cycle arrest and apoptosis in human lung squamous carcinoma CH27 cells,” Anticancer Research, vol. 25, no. 2, pp. 959–964, 2005. View at Google Scholar · View at Scopus
  45. C. S. Ong, J. Zhou, C. N. Ong, and H. M. Shen, “Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3β-cyclin D1 pathway,” Cancer Letters, vol. 298, no. 2, pp. 167–175, 2010. View at Publisher · View at Google Scholar · View at Scopus